LMRA Was up 35.48% on volume of 694,894 >3x its ADV & continued to hold its gain AHs.
bigcharts.marketwatch.com
As previously mentioned,I traded LMRA in 2006 during its Oct-Nov run, which started at a level lower than its present one. At that time what caused the spike was its presentation at the Westergaard SmallCap conference & the announcement of the successful testing of its millimeter wave wireless bridge, which reportedly,is able to transmit vast amounts of data by a variety of high speed telecommunications networks.
bigcharts.marketwatch.com.
My interest on LMRA is because of its NanoCapture arrays and ProteomicProcessor, a field in which there is a good amount of competition with several companies involved,many of them in this list:
functionalgenomics.org.uk
In July LMRA formed a wholly owned subsidiary, Plexera Bioscience,where it transfered the operations of its bioscience business and is led by Joseph Vallner, Ph.D, who was before at CEGE & years ago at Syntex & GD Searle.
Leroy Hood, M.D., Ph.D., president and co-founder of the Institute for Systems Biology, & Josh LaBaer, M.D., Ph.D., founder and director of the Institute of Proteomics at Harvard Medical School, joined LMRA's Scientific Advisory Board in April 2006.
ir.lumera.com
Disclosure: I sold most of my shares in 2006 at $10, but still have a small position.
The stock is starting to get off from the DT coming from its Oct15 H at $4.74 (LMRA has substantial amount of resistance at that level from its Jul, Sep & Oct Hs.)
The analysts don't seem to have an advertised target for LMRA of which I am aware, but I will continue to hold mine around $5 for 2008, which would still be a nice gain from present levels. Of course if it can close above $5 & it has some good news I may have to raise that "target".<g>
bigcharts.marketwatch.com
Bernard |
